Director, Division of Cardiology
Sankuro Hospital, Japan
Dr. Ito works as a cardiologist at Division of Cardiology, Sankuro Hospital, Toyota, Japan since February,2016. Dr. Ito also works as a director at Japan Cardiovascular Imaging Core Laboratory (J-CICL, Tokyo, Japan) in many interventional randomized controlled trials. He works as a medical superviser of Running Magazine “Running Style”. Dr. Ito completed his M.D. from Nagoya City University in 1984 and Ph.D. (Cardiology) from Nagoya City University Graduate School of Medical Sciences in 1994. He has vast experience in cardiology, especially interventional cardiology (coronary and peripheral artery disease) and cardiac rehabilitation. He worked at a few affiliations of Nagoya City University from 1984-1996 as a cardiologist. He was a research scientist at the Washington (DC) Hospital Center (Interventional Cardiology) from 1996-1998. He worked at Nagoya City University as an instructor (1998-2001). He was a director at Toyohashi Heart Center (2001-2004), at Moriyama Municipal Hospital (2004-2007), and at Nagoya City East Medical Center (2007-2016).
His major area of research includes General cardiology Interventional cardiology, especially in invasive coronary imaging (QCA, OCT, IVUS etc.) Cardiac rehabilitation Physical activity and fitness Medical fitness Sports medicine Running
Chairman and CEO
International Center for Cardio Thoracic & Vascular Diseases, India
Dr. K.M.Cherian is presently working as Chairman and CEO of International Centre for Cardio Thoracic & Vascular Diseases. He is one of the most decorated heart surgeons in India as he is also the Honorary Surgeon to the President of India. Dr. K.M. Cherian has completed his F.R.A.C.S. from Royal Australasian College of Surgeons, Sydney and performed the first Successful Coronary Artery Graft in India. Dr. Cherian is the First and the only Indian’s name engraved in one of the stones in Kos Island, Greece, the birth place of the medical professional, Hippocrates, the “Father of Medicine”, on the occasion of World Society of Cardio Thoracic Surgeons held between 30th April – 3rd May.
Stem Cells, Tissue Engineering, Xenografts, Cardiology and Heart Transplantation